Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at raps@raps.org if you need assistance.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
This comprehensive resource covers product change evaluation, postmarket surveillance, audit/inspection compliance, and various other laws and regulations pertaining to maintaining a product on the market.
Hear from leaders around the globe as they share insights about their experiences and lessons learned throughout their certification journey.
| 22 February 2012
According to a report by PMLIVE Intelligence Online, the European Medicines Agency (EMA) is setting its sights on new pharmacovigilance laws and fighting counterfeit medicines.
The goals are outlined in the new EMA Work Programme 2012, which also outlines some cost-cutting measures for the current year. Despite these reductions, the EMA is expecting to increase its focus on the areas of pharmacovigilance and anti-counterfeiting.
The report states these efforts are part of the EMA's "Road Map to 2015," which was launched in 2010.
Read more:PMLIVE Intelligence Online: EMA to Focus on Pharmacovigilance and Combating Counterfeits in 2012
Tags: Counterfeiting, Latest News, pharmacovigilance